Lin Tan
8 Papers
Lin Tan is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.
Dong Ji,Dawei Zhang,Jing Xu,Zhu Chen,Tieniu Yang,Peng Zhao,Guofeng Chen,Gregory Cheng,Yudong Wang,Jingfeng Bi,Lin Tan,George Lau,Enqiang Qin +12 more
TL;DR: Using the CALL score model, clinicians can improve the therapeutic effect and reduce the mortality of COVID-19 with more accurate and reasonable resolutions on medical resources.
692
Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B.
Dong-Ming Ji,Yan Chen,Jingfeng Bi,Qinghua Shang,Huabao Liu,Jia-Bo Wang,Lin Tan,Jing Wang,Yongping Chen,Qin Li,Qing-Hua Long,Laicheng Song,Li Jiang,Guangming Xiao,Zujiang Yu,Liang Chen,Xiaodong Wang,Da Chen,Zhiqin Li,Zheng Dong,Yongping Yang +20 more
TL;DR: Wang et al. as discussed by the authors showed that entecavirus (ETV) plus BRC, an anti-fibrotic traditional Chinese medicine, can further reduce the risk of hepatocellular carcinoma (HCC) in treatment-naïve Chinese patients with chronic hepatitis B and an Ishak fibrosis score of ≥ 3 points derived from a parent double-blind randomized placebo-controlled trial.
32
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy
Xiujuan Chang,Yinying Lu,Chao Sun,Xiao-Song Li,Wenjuan Du,Qinghua Shang,Laicheng Song,Qing-Hua Long,Qin Li,Huabao Liu,Jing Wang,Zujiang Yu,Jiang Li,Guangming Xiao,Li Mi Qin Li,Liang Chen,Lin Tan,Yongping Chen,Yongping Yang +18 more
TL;DR: HBeAg-positive patients with a low HBcrAg level or old age, and HBeAg-negative patients with HBV genotype C tended to develop progressive hepatic fibrosis and had a high incidence of HCC and decompensated cirrhosis, even on ETV treatment.
2
Low-level viremia increases the risk of adverse long-term outcomes in entecavir-treated patients with chronic hepatitis B.
Dong Ji,Meng-Wen He,Wen-Chang Wang,Wei Han,Yan Chen,Yan Liu,Le Li,Xu-Yang Li,Yi-Fan Guo,Wucai Yang,Zheng Dong,Chunyan Wang,Jing Xu,Lin Tan,George Lau,Yongping Yang +15 more
Assessment of nomogram model for the prediction of esophageal variceal hemorrhage in hepatitis B-induced hepatic cirrhosis
Jing Xu,Lin Tan,Ning Jiang,Fengcheng Li,Jinling Wang,Beibei Wang +5 more
TL;DR: The authors' non-invasive NMs based on the platelet distribution width and spleen length may be used to predict EV hemorrhage in HBV-induced cirrhotic patients and can help clinicians to increase diagnostic performance leading to improved treatment measures.